Radically Genuine Podcast with Dr. Roger McFillin 117. The Power of the Placebo Response in Mental Health
Jan 4, 2024
Unpacking the surprising potential of the placebo effect in mental health, the discussion questions traditional treatments like SSRIs. It emphasizes informed consent as a pathway to patient empowerment and highlights how belief systems can shape recovery. Insights include the importance of therapist confidence and the impact of collective consciousness on individual health choices. Practical strategies are shared to harness placebo responses for improved outcomes, challenging conventional psychiatry and promoting a more holistic approach to mental wellness.
AI Snips
Chapters
Transcript
Episode notes
Antidepressants Often Match Placebo Outcomes
- Many antidepressant trials show no clinically relevant advantage over placebo despite measurable effects.
- Roger McFillin cites short trials (6–8 weeks) and high placebo response rates (30–50%), so drug benefits often mirror expectancy effects.
Offer Full Informed Consent For Antidepressants
- Provide true informed consent before prescribing antidepressants including long‑term unknowns and alternatives.
- Roger McFillin lists 10 informed consent points: short trials, natural recovery, risks (suicide, sexual dysfunction), and alternatives like therapy.
Anecdotes Often Reflect Placebo Scale
- Placebo responses are common and large in mental health, so clinicians' anecdotal reports of 'it worked' often reflect expectancy.
- Using US prevalence numbers Roger estimates millions report benefit from placebo-level effects.